Key Dates

Related Announcements

• October 30, 2024 - Dissemination and Implementation Research in Health (R21 Clinical Trial Optional). See PAR-25-143
• October 30, 2024 - Dissemination and Implementation Research in Health (R01 Clinical Trial Optional). See PAR-25-144

Issued by

National Cancer Institute (NCI)

Purpose

This Notice is to inform the research community that the Funding Opportunity Goal(s) statement for the "Dissemination and Implementation Research in Health" Notices of Funding Opportunity PAR-25-143 and PAR-25-144 has been modified to reflect the broad mission of the NIH as opposed to a specific mission of any particular participating institute, center, or office.

Part 1. Overview Information 

Funding Opportunity Goal(s)

Currently reads:

The overall goals of this NOFO is to reduce cancer risk, incidence, morbidity, and mortality and enhance quality of life in cancer survivors through an orderly sequence from research on interventions and their impact in defined populations to the broad, systematic application of the research results through dissemination and diffusion strategies.

Corrected to read (in italics):

 NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. 

All other aspects of PAR-25-143 and PAR-25-144 remain unchanged.

Inquiries

Please direct all inquiries to:

Gila Neta, PhD
National Cancer Institute (NCI)
Telephone: 240-276-6785
Email: [email protected]